Decreased Susceptibility to Polymyxin B during Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection

This publication has 11 references indexed in Scilit:

• Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies
  Clinical Microbiology & Infection, 2008
• In Vitro Activity of Tigecycline against Multidrug-Resistant Acinetobacter baumannii and Selection of Tigecycline-Amikacin Synergy
  Antimicrobial Agents and Chemotherapy, 2008
• Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
  Journal of Antimicrobial Chemotherapy, 2008
• Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control study
  Critical Care Medicine, 2008
• Antimicrobial Activities of Tigecycline and Other Broad-Spectrum Antimicrobials Tested against Serine Carbapenemase- and Metallo-β-Lactamase-Producing Enterobacteriaceae : Report from the SENTRY Antimicrobial Surveillance Program
  Antimicrobial Agents and Chemotherapy, 2008
• Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster
  Journal of Antimicrobial Chemotherapy, 2007
• In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis
  Journal of Antimicrobial Chemotherapy, 2006
• Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
  Clinical Infectious Diseases, 2005
• Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
  Published by Elsevier ,2004
• Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain ofKlebsiella pneumoniae
  Antimicrobial Agents and Chemotherapy, 2001